Subjects were assigned randomly to groups given simeprevir ( @ mg/day ) and sofosbuvir ( @ mg/day ) ( n = @ in the final analysis ) or peginterferon alfa @b ( @ mcg/kg/wk ) , ribavirin ( @-@ mg/day ) , and sofosbuvir ( @ mg/day ) ( n = @ in the final analysis ) .